Flux Power Holdings Inc vs Novavax Inc — how do they compare? Flux Power Holdings Inc trades at $0.59 (market cap $11.23M), while Novavax Inc trades at $7.94 (market cap $1.31B). The key difference: Novavax Inc is far larger — about 116.7× Flux Power Holdings Inc's market cap, and Novavax Inc is trading nearer its 52-week high, Flux Power Holdings Inc nearer its low. Which is the better fit depends on your goals.
| FLUX | NVAX | |
|---|---|---|
Market Cap | $11.23M | $1.31B |
Sector | Utilities | Health |
52-Week High | $6.66 | $11.19 |
52-Week Low | $0.51 | $6.22 |
Enterprise Value | $17.39M | $889.30M |
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.5408, up 3.21% today, but technical indicators signal a bearish trend with selling pressure across moving averages. The company reported revenue of $66.43M in 2025 but a net loss of $6.67M, with profitability metrics like ROE at -52.27% reflecting operational challenges. Recent news highlights product launches like SkyEMS 3.0 and an upcoming earnings call on August 20, 2026.
Despite unanimous analyst buy ratings, FLUX faces significant risks from persistent losses and negative cash flow projections. Investment appeal hinges on execution of growth initiatives in lithium-ion storage, but high volatility and competitive pressures warrant caution for equity investors.
Novavax (NVAX) trades at $7.97, up 1.01% with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported strong Q2 2026 results, beating revenue and earnings estimates while raising full-year guidance. Despite negative profitability metrics, valuation ratios appear attractive with P/E of 3.14 and EV/EBITDA of 1.72. Recent news highlights progress with Sanofi partnership and cost reduction initiatives.
The outlook remains challenged by negative cash flows and accumulated deficits, but analyst sentiment is positive with 74% buy ratings. Key risks include ongoing operational losses and vaccine demand volatility, while potential upside exists from partnership milestones and adjuvant platform expansion. The stock presents a high-risk opportunity with significant analyst support despite fundamental weaknesses.
Trailing returns across standard periods
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →